FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,611 | +222.5% | 73,401 | +624.2% | 0.00% | – |
| Q2 2023 | $48,247 | -99.2% | 10,136 | -93.3% | 0.00% | -100.0% |
| Q3 2020 | $6,058,000 | -46.0% | 151,564 | -53.6% | 0.03% | -57.5% |
| Q2 2020 | $11,214,000 | -26.8% | 326,836 | -58.2% | 0.07% | -9.9% |
| Q4 2019 | $15,319,000 | -16.4% | 782,783 | -33.7% | 0.08% | -28.3% |
| Q3 2019 | $18,327,000 | +52.1% | 1,180,089 | +98.8% | 0.11% | +79.4% |
| Q2 2019 | $12,048,000 | +37.1% | 593,500 | +18.7% | 0.06% | +57.5% |
| Q1 2019 | $8,785,000 | – | 500,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |